Repositorio Dspace

Listar por autor "Eichau, S"

Listar por autor "Eichau, S"

Ordenar por:Orden:Resultados:

  • Meca-Lallana, José-Eustasio; Martínez-Yélamos, Sergio; Eichau, S; Llaneza, MA; Martín-Martínez, J; Martínez, JPena; Meca-Lallana, Virginia; Torres, AMAlonso; Torres, EMoral; Rio, J; Calles, C; Luque, AAres; Ramio-Torrenta, Lluis; Sola, MEMarzo; Prieto, JM; Martínez-Gines, ML; Arroyo, R; Otano-Martínez, MA; Ruiz, LBrieva; Gómez-Gutiérrez, M; Rodríguez-Antigüedad, Alfredo; Sánchez-Seco, VG; Costa-Frossard, Lucienne; Hernández-Pérez, MA; Pascual, LLandete; González-Platas, M; Oreja-Guevara, Celia (ELSEVIER ESPANA SLU, 2024-03)
    The last consensus statement of the Spanish Society of Neurology's Demyelinating Diseases Study Group on the treatment of multiple sclerosis (MS) was issued in 2016. Although many of the positions taken remain valid, there ...
  • Otero-Romero, S; Rodríguez-García, J; Vilella, A; Ara, J-R; Brieva, L; Calles, C; Carmona, O; Casanova, V; Costa-Frossard, Lucienne; Eichau, S; García-Merino, J-A; García-Vidal, C; González-Platas, M; Llaneza, M; Martínez-Gines, M; Meca-Lallana, José-Eustasio; Prieto, J-M; Rodríguez-Antigüedad, Alfredo; Tintore, M; Blanco, Y; Moral, E (ELSEVIER ESPANA SLU, 2021-01)
    BACKGROUND: The recent development of highly effective treatments for multiple sclerosis (MS) and the potential risk of infectious complications require the development of prevention and risk minimisation strategies. ...